Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Titan Bio-Tech: Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.
News Announcement

Titan Bio-Tech: Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.

04-Nov-2025 Follow Value Research Online on Google download pdfDownload PDF Titan Bio-Tech

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the unaudited standalone & consolidated financial results for the second quarter & half year ended September 30 2025

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month